Qianhe Zhou, PhD

Principal Scientist
Foghorn Therapeutics

I am currently a principal scientist in the biology department at Foghorn Therapeutics. I joined Foghorn Therapeutics in March 2017. Before that, I was a scientist at Biogen between 2015-2017. I gained my PhD in biological science at Columbia University in 2011 and trained as postdoc at Novartis oncology department between 2012-2015.

Poster(s):

• (P 187) PRECLINICAL VALIDATION OF TARGET ENGAGEMENT ASSAYS AND INVESTIGATION OF MECHANISTIC IMPACTS OF FHD-609, A CLINICAL-STAGE BRD9 DEGRADER BEING DEVELOPED FOR THE TREATMENT OF SYNOVIAL SARCOMA